Vivos Therapeutics Inc (VVOS) Stock Price, Quote & News

Company Profile

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children....

Industry: Medical Devices

Sector: Healthcare

Phone: 844 672 4357

Website: www.vivos.com

Address:

7921 Southpark Plaza, Suite 210, Littleton, United States

HopehelpsU Aug. 19 at 4:54 PM

$VVOS ADDED a few. Bring it.

0 · Reply

Are_You_Experienced Aug. 19 at 4:41 PM

$VVOS I think at 4:59 pm ResMed makes a $5-10B offer!!!

1 · Reply

Are_You_Experienced Aug. 19 at 4:32 PM

$VVOS LOCKED UP LOL

0 · Reply

Muskvoice Aug. 19 at 4:23 PM

$VVOS Volume 13,231

0 · Reply

Muskvoice Aug. 19 at 4:21 PM

$VVOS

0 · Reply

BioRich Aug. 19 at 3:08 PM

$VVOS I think we see a run-up going into AH earnings. I really liked what I heard last call about their expansion and growth so I'm excited to see what they announce this go around. Another ST user turned me onto this gem several months ago and I've been happy with it ever since. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some money. Cheers! $XBI $IBB $IBBQ

0 · Reply

KLM_77 Aug. 19 at 3:05 PM

$VVOS No shares locked up definitely to the moon 🚀

0 · Reply

skips200k Aug. 19 at 2:54 PM

$VVOS WOW. Certainly looks like everyone is just waiting. The after hour % movement is going to be insane. Lots of short-term money to be made. Long-term 20+. Very

0 · Reply

Are_You_Experienced Aug. 19 at 2:22 PM

$VVOS It seems there are no shares to trade with it's so completely locked up. I have some for sale @ $44.92 if anyone is interested.

0 · Reply

riked777 Aug. 19 at 1:48 PM

$VVOS anyone have history of how this stock performs on new of the given day? I know each earnings is different and brings new information but just curious how it has operated on days given of earnings? Has it dropped? Has it gone up? Any information given is great appreciated. Holding long and strong because I believe in the company but want an idea of what to expect. Thank you all!

1 · Reply

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

Jun 26, 2025, 8:30 AM EDT - 7 weeks ago

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

May 15, 2025, 7:31 PM EDT - 3 months ago

Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript

May 14, 2025, 9:15 AM EDT - 3 months ago

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

Apr 16, 2025, 8:30 AM EDT - 4 months ago

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

Apr 1, 2025, 12:18 AM EDT - 5 months ago

Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:20 PM EDT - 5 months ago

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Mar 28, 2025, 8:30 AM EDT - 5 months ago

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Dec 23, 2024, 8:00 AM EST - 8 months ago

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 14, 2024, 11:31 PM EST - 9 months ago

Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 5:00 PM EST - 9 months ago

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Oct 8, 2024, 7:30 AM EDT - 11 months ago

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

Sep 18, 2024, 7:00 AM EDT - 11 months ago

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Aug 15, 2024, 2:05 PM EDT - 1 year ago

Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:05 PM EDT - 1 year ago

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Aug 14, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

Jun 27, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Jun 12, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

May 17, 2024, 9:02 PM EDT - 1 year ago

Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:05 PM EDT - 1 year ago

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

May 14, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call

Apr 9, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Mar 28, 2024, 11:10 PM EDT - 1 year ago

Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Mar 28, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Feb 6, 2024, 7:30 AM EST - 1 year ago

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Jan 8, 2024, 7:30 AM EST - 1 year ago

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA

Dec 11, 2023, 7:30 AM EST - 1 year ago

Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”

Nov 29, 2023, 11:09 AM EST - 1 year ago

Vivos Therapeutics' stock soars as sleep apnea device gets regulatory clearance

Nov 29, 2023, 7:44 AM EST - 1 year ago

US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea

Nov 29, 2023, 7:30 AM EST - 1 year ago

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

Nov 17, 2023, 7:12 PM EST - 1 year ago

Vivos Therapeutics, Inc. (VVOS) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 4:05 PM EST - 1 year ago

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

Nov 9, 2023, 4:30 PM EST - 1 year ago

Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call

Nov 2, 2023, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Closes $4 Million Private Placement

Oct 26, 2023, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Reverse Stock Split

Oct 24, 2023, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare

Oct 11, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine

Oct 5, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion

Oct 4, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers

Oct 2, 2023, 7:30 AM EDT - 2 years ago

New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference

Aug 16, 2023, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update

Aug 16, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call

Aug 14, 2023, 5:06 PM EDT - 2 years ago

Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call

Aug 10, 2023, 8:31 PM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call

Jun 9, 2023, 12:24 PM EDT - 2 years ago

Vivos Therapeutics, Inc. (VVOS) Q1 2023 Earnings Call Transcript

Jun 8, 2023, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update

Jun 6, 2023, 4:30 PM EDT - 2 years ago

Vivos Therapeutics Schedules Release of First Quarter 2023 Financial Results and Conference Call

May 1, 2023, 7:30 AM EDT - 2 years ago

Clinical Study Shows 92% of Patients Report Resolution of Migraine Headaches Using Vivos' POD® Appliance Treatment

Mar 31, 2023, 6:05 PM EDT - 2 years ago

Vivos Therapeutics, Inc. (VVOS) Q4 2022 Earnings Call Transcript

HopehelpsU Aug. 19 at 4:54 PM

$VVOS ADDED a few. Bring it.

0 · Reply

Are_You_Experienced Aug. 19 at 4:41 PM

$VVOS I think at 4:59 pm ResMed makes a $5-10B offer!!!

1 · Reply

Are_You_Experienced Aug. 19 at 4:32 PM

$VVOS LOCKED UP LOL

0 · Reply

Muskvoice Aug. 19 at 4:23 PM

$VVOS Volume 13,231

0 · Reply

Muskvoice Aug. 19 at 4:21 PM

$VVOS

0 · Reply

BioRich Aug. 19 at 3:08 PM

0 · Reply

KLM_77 Aug. 19 at 3:05 PM

$VVOS No shares locked up definitely to the moon 🚀

0 · Reply

skips200k Aug. 19 at 2:54 PM

$VVOS WOW. Certainly looks like everyone is just waiting. The after hour % movement is going to be insane. Lots of short-term money to be made. Long-term 20+. Very

0 · Reply

Are_You_Experienced Aug. 19 at 2:22 PM

$VVOS It seems there are no shares to trade with it's so completely locked up. I have some for sale @ $44.92 if anyone is interested.

0 · Reply

riked777 Aug. 19 at 1:48 PM

1 · Reply

GamblerDan Aug. 19 at 1:29 PM

$VVOS Call is scheduled for 5pm et today https://vivos.com/vivos-therapeutics-schedules-release-of-second-quarter-2025-financial-results-and-conference-call/

0 · Reply

skips200k Aug. 19 at 12:37 PM

$VVOS Earnings and conference call after close today. Let's get some good guidance and visibility. Very

0 · Reply

KLM_77 Aug. 19 at 8:15 AM

$VVOS hope this delay in announcement brings something positive. I am optimistic we noticed two majors hiring + Nevada center this can be unprecedented to VVOS .

0 · Reply

xbizo Aug. 18 at 10:57 PM

$VVOS Tomorrow supposedly, but they also said they would beat the five day extension, which would have been today. No word from the company about an earnings call.

1 · Reply

JD101 Aug. 18 at 9:21 PM

$VVOS soon 🚀

0 · Reply

Are_You_Experienced Aug. 18 at 7:39 PM

$VVOS 10.10%. @ $4.53

0 · Reply

Are_You_Experienced Aug. 18 at 7:26 PM

$VVOS The squeeze has started!!

0 · Reply

Are_You_Experienced Aug. 18 at 7:25 PM

$VVOS up 9% and climbing

0 · Reply

Are_You_Experienced Aug. 18 at 7:01 PM

$VVOS The T&S ticker is so restrained, all locked up but who sells 7 shares or 12 shares. I know mm's telegraph each other on needs that way.

0 · Reply

CroatoanCapital Aug. 18 at 5:59 PM

$VVOS To meet SEC regulations around filing Form 12b-25 (“NT 10-Q”), Vivos needs to file the 10-Q by Tuesday at the latest. Unless they need more time, we can expect the 10-Q filing by Tuesday. They could put out a press release Tuesday with earnings and a conference call time Tuesday afternoon or Wednesday morning. They could also wait until Wednesday morning to put out an earnings press release with a conference call time set for some point on Wednesday.

1 · Reply

Are_You_Experienced Aug. 18 at 3:52 PM

$VVOS @shem-the-penman This guy has done some really good dd for investors here! Thx Joe!

1 · Reply

KLM_77 Aug. 18 at 3:29 PM

$VVOS when this squeeze you can’t chase or buy it . Smart money in 😊.

0 · Reply

Market Cap	24.21M
Revenue (ttm)	15.03M
Net Income (ttm)	-11.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-74.12%
Debt to Equity Ratio	0.00

Volume	30,059
Avg Vol	913,176
Day's Range	N/A - N/A
Shares Out	5.89M
Stochastic %K	54%
Beta	7.03
Analysts	Sell
Price Target	$4.22